Bing Kan

46 papers receiving 1.2k citations

Peers

Bing Kan
Comparison fields: 5 of 71
  • Drug Discovery 11
  • Molecular Medicine 182
  • Biomaterials 332
  • Pharmaceutical Science 155
  • Genetics 116
Replace Ling Mei with:
Ling Mei China
Guangchao Qing China
Behrooz Johari Iran
Xiangang Huang United States
Funan Liu China
Mohammad Doroudian Iran
João Conniot Portugal
Yingqiu Qi China
Shisong Han China
Mengnan Zhao China
Bing Kan relative to Ling Mei China Ling Mei's profile →
Citations per field
00.5×1.5×1.8×
Ling Mei · 1×
Citations per year

Countries citing papers authored by Bing Kan

Since Specialization
Citations

This map shows the geographic impact of Bing Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Kan more than expected).

Fields of papers citing papers by Bing Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Kan. The network helps show where Bing Kan may publish in the future.

Co-authors

The 25 scholars most cited alongside Bing Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bing Kan Line = papers co-authored together Bing Kan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008144
2 2009108
3 200398
4 200772
5 200865
6 200857
7 200756
8
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2.
200351
9 200743
10 201139
11 200838
12 201329
13 200428
14 200526
15 200926
16 200525
17 201325
18 200824
19 200924
20 200823

About Bing Kan

Bing Kan is a scholar working on Biomaterials, Pharmaceutical Science, Immunology, Molecular Biology and Molecular Medicine, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (7 papers), Angiogenesis and VEGF in Cancer (7 papers), biodegradable polymer synthesis and properties (4 papers), Advanced Drug Delivery Systems (4 papers), Virus-based gene therapy research (4 papers) and Hydrogels: synthesis, properties, applications (4 papers). The work is most often cited by research in Drug Discovery (11 citations), Molecular Medicine (182 citations), Biomaterials (332 citations), Pharmaceutical Science (155 citations) and Genetics (116 citations). Bing Kan has collaborated with scholars based in China and Singapore. Frequent co-authors include Zhiyong Qian, Yuquan Wei, Xia Zhao, Feng Luo, Maling Gou, Mei Dai, Xiancheng Chen, Yongsheng Wang, Changyang Gong and Ma Ling Gou. Their work appears in journals such as Anti-Cancer Drugs, International Journal of Pharmaceutics, Journal of Biomedical Materials Research Part A, Molecular Therapy and Journal of Biomedical Nanotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact